On Thursday, June 20, 2024, at the Annual Shareholders' Meeting of Kaituo Pharmaceuticals - B (09939.HK), all the proposed resolutions listed in the notice have been formally approved by the shareholders through voting. Executive Director Lu Qun and non-executive director Liu Chengwei retired after the annual shareholders' meeting and did not run for re-election as the company's executive director and non-executive director due to personal affairs. Mr. Liu also resigned as a member of the audit committee after retiring as a non-executive director.

In addition, independent non-executive director Tong Liang was appointed as a member of the Audit Committee, effective immediately after the end of the Annual Shareholders' Meeting.